BackgroundA-Z Listing of EPARs

EPARs for authorised medicinal products for human use


Please click on a letter to view an indexed list of products:

l
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

P

Name INN Revision Published Additional Information
Pandemic Influenza Vaccine H5N1 Baxter Common name: Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)   17/12/09  
Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals Common name: Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/VietNam/1194/2004 NIBRG-14   17/12/09  
Pandemrix Exceptional circumstances - Click for more information Common name: Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted); A/California/7/2009 (H1N1)v like strain (X-179A) Rev. 8 04/03/10 Press Release - (04/12/09)
Press Release - (25/09/09)
Questions ans Answers - (25/09/09)
Pantecta Control INN: pantoprazole   22/06/09  
Pantoloc Control INN: pantoprazole Rev. 1 05/03/10  
Pantozol Control INN: pantoprazole   22/06/09  
Panretin INN: alitretinoin Rev. 8 01/02/10  
Parareg INN: cinacalcet Rev. 6 14/05/09 Public Statement on withdrawal of Marketing Authorisation 15/05/09)
Patrex INN: sildenafil Rev. 4   Non-renewal of the Marketing Authorisation (18/08/05)
Paxene INN: paclitaxel Rev. 14 13/08/09  
Pedea Orphan Medicinal Product - Click for more information INN: ibuprofen Rev. 7 18/08/09  
Pegasys INN: peginterferon alfa-2a Rev. 16 16/11/09  
PegIntron INN: peginterferon alfa-2b Rev. 19 22/01/10  
Pelzont INN: nicotinic acid / laropiprant Rev. 5 24/02/10  
Pergoveris INN: follitropin alfa / lutropin alfa Rev. 4 31/07/09  
PhotoBarr Orphan Medicinal Product - Click for more information INN: porfimer sodium Rev. 6 21/04/09  
Pioglitazone metformin hydrochloride Takeda INN: pioglitazone/metformin     See Glubrava
Plavix INN: clopidogrel Rev. 21 13/10/09 Public Statement (02/06/09)
Posaconazole SP INN: posaconazole Rev. 5 27/01/09 Public Statement on withdrawal of Marketing Authorisation 04/08/09)
Prandin INN: repaglinide Rev. 9 18/02/09  
Pradaxa INN: dabigatran etexilate Rev. 5 15/12/09  
Pramipexole Teva INN: pramipexole Rev. 2 28/08/09  
Preotact INN: parathyroid hormone (rDNA) Rev. 1 25/01/08  
Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals Common name: Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/Vietnam/1194/2004 NIBRG-14 Rev. 3 07/12/09  
Prepandrix Common name: prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) Rev. 3 21/12/09  
Prevenar Common Name: pneumococcal saccharide conjugated vaccine, absorbed Rev. 16 08/10/09  
Prevenar 13 Common Name: pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)    08/01/10  
Prezista INN: darunavir Rev. 12 05/11/09  
Prialt Orphan Medicinal Product - Click for more informationExceptional circumstances - Click for more information INN: Ziconotide Rev. 9 26/01/10  
Pritor INN: telmisartan Rev. 16 08/02/10 Press Release (24/04/08)
Q&A (24/04/08)
PritorPlus INN: telmisartan/hydrochlorothiazide Rev. 18 26/11/09 Press Release (24/04/08)
Q&A (24/04/08)
Privigen INN: human normal immunoglobulin (IVIg)  Rev. 4 11/09/09  
Procoralan INN: ivabradine Rev. 5 22/01/10  
Procomvax Common name: haemophilus b conjugate (Meningoccocal Protein conjugate) and hepatitis B (recombinant) vaccine Rev. 9 09/04/08 Public Statement on the Non-renewal of the Marketing Authorisation in the EU (29/05/09)
Prometax INN: rivastigmine Rev. 17 13/02/09  
ProQuad Common name: measles, mumps, rubella and varicella vaccine (live) Rev. 6 11/03/10  
Protaphane INN: insulin human (rDNA) Rev. 6 09/12/09  
Protelos INN: strontium ranelate Rev. 7 26/02/10 Press Release (16/11/07)
Protopic INN: tacrolimus Rev. 11 06/07/09  
Protopy INN: tacrolimus Rev. 10 09/11/07 Marketing authorisation withdrawn (08/10/08)
Puregon INN: follitropin beta Rev. 17 11/03/10  
Pylobactell INN: 13 C-urea Rev. 7 14/08/08